CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based therapeutics, announced that the Company will release its first quarter 2015 financial results after market close on Monday, May 11, 2015.
Help employers find you! Check out all the jobs and post your resume.